Coagulation testing before epidural analgesia at delivery: Cost analysis

Franca Franchi, Buthaina Ibrahim, Federica Rossi, Maria Luisa Maspero, Oronzo Morabito, Daniela Asti, Paolo Bucciarelli, Eugenia Biguzzi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Backgound: The usefulness of coagulation tests performed before epidural analgesia for surgery or to alleviate labour pain is controversial. The aims of this study were: 1) to evaluate the prevalence of abnormal tests in a large cohort of healthy pregnant women and their association with epidural hematoma; 2) to assess the approach of the anesthesiologists to women with abnormal tests; 3) to evaluate the cost of performing coagulation tests before epidural analgesia in all healthy pregnant women. Methods: Data regarding epidural analgesia, epidural hematoma, PT, APTT, fibrinogen and platelet count were extracted from medical charts. Results: There was no case of epidural hematoma in 2546 pregnant women undergoing epidural analgesia. PT and APTT results were obtained in 2871 women; fibrinogen in 4063 women; platelet count in 5090 women. Three of them (0.1%) had a prolonged PT, 4 (0.14%) had a prolonged APTT, 27 (0.53%) had platelets ≤100 × 109/L and 37 (0.91%) had plasma fibrinogen levels <3 g/L. No further tests were requested by the anesthesiologists in these women. Only women with platelets <80 × 109/L were denied epidural analgesia. Based on the data from the literature on the frequencies of epidural hematoma after epidural analgesia, a total cost ranging from 4.5 to 40 million Euros to perform coagulation tests would be necessary to avoid one case of epidural hematoma. Discussion: Unselected coagulation tests before epidural analgesia are not recommended, because epidural hematoma is extremely rare in healthy pregnant women and the cost of screening is not justified.

Original languageEnglish
Pages (from-to)18-20
Number of pages3
JournalThrombosis Research
Volume128
Issue number1
DOIs
Publication statusPublished - Jul 2011

Fingerprint

Epidural Analgesia
Hematoma
Costs and Cost Analysis
Pregnant Women
Fibrinogen
Platelet Count
Blood Platelets
Labor Pain

ASJC Scopus subject areas

  • Hematology

Cite this

Franchi, F., Ibrahim, B., Rossi, F., Maspero, M. L., Morabito, O., Asti, D., ... Biguzzi, E. (2011). Coagulation testing before epidural analgesia at delivery: Cost analysis. Thrombosis Research, 128(1), 18-20. https://doi.org/10.1016/j.thromres.2011.02.023

Coagulation testing before epidural analgesia at delivery : Cost analysis. / Franchi, Franca; Ibrahim, Buthaina; Rossi, Federica; Maspero, Maria Luisa; Morabito, Oronzo; Asti, Daniela; Bucciarelli, Paolo; Biguzzi, Eugenia.

In: Thrombosis Research, Vol. 128, No. 1, 07.2011, p. 18-20.

Research output: Contribution to journalArticle

Franchi F, Ibrahim B, Rossi F, Maspero ML, Morabito O, Asti D et al. Coagulation testing before epidural analgesia at delivery: Cost analysis. Thrombosis Research. 2011 Jul;128(1):18-20. https://doi.org/10.1016/j.thromres.2011.02.023
Franchi, Franca ; Ibrahim, Buthaina ; Rossi, Federica ; Maspero, Maria Luisa ; Morabito, Oronzo ; Asti, Daniela ; Bucciarelli, Paolo ; Biguzzi, Eugenia. / Coagulation testing before epidural analgesia at delivery : Cost analysis. In: Thrombosis Research. 2011 ; Vol. 128, No. 1. pp. 18-20.
@article{0100260a253b45ba93942367fe22dbc6,
title = "Coagulation testing before epidural analgesia at delivery: Cost analysis",
abstract = "Backgound: The usefulness of coagulation tests performed before epidural analgesia for surgery or to alleviate labour pain is controversial. The aims of this study were: 1) to evaluate the prevalence of abnormal tests in a large cohort of healthy pregnant women and their association with epidural hematoma; 2) to assess the approach of the anesthesiologists to women with abnormal tests; 3) to evaluate the cost of performing coagulation tests before epidural analgesia in all healthy pregnant women. Methods: Data regarding epidural analgesia, epidural hematoma, PT, APTT, fibrinogen and platelet count were extracted from medical charts. Results: There was no case of epidural hematoma in 2546 pregnant women undergoing epidural analgesia. PT and APTT results were obtained in 2871 women; fibrinogen in 4063 women; platelet count in 5090 women. Three of them (0.1{\%}) had a prolonged PT, 4 (0.14{\%}) had a prolonged APTT, 27 (0.53{\%}) had platelets ≤100 × 109/L and 37 (0.91{\%}) had plasma fibrinogen levels <3 g/L. No further tests were requested by the anesthesiologists in these women. Only women with platelets <80 × 109/L were denied epidural analgesia. Based on the data from the literature on the frequencies of epidural hematoma after epidural analgesia, a total cost ranging from 4.5 to 40 million Euros to perform coagulation tests would be necessary to avoid one case of epidural hematoma. Discussion: Unselected coagulation tests before epidural analgesia are not recommended, because epidural hematoma is extremely rare in healthy pregnant women and the cost of screening is not justified.",
author = "Franca Franchi and Buthaina Ibrahim and Federica Rossi and Maspero, {Maria Luisa} and Oronzo Morabito and Daniela Asti and Paolo Bucciarelli and Eugenia Biguzzi",
year = "2011",
month = "7",
doi = "10.1016/j.thromres.2011.02.023",
language = "English",
volume = "128",
pages = "18--20",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Coagulation testing before epidural analgesia at delivery

T2 - Cost analysis

AU - Franchi, Franca

AU - Ibrahim, Buthaina

AU - Rossi, Federica

AU - Maspero, Maria Luisa

AU - Morabito, Oronzo

AU - Asti, Daniela

AU - Bucciarelli, Paolo

AU - Biguzzi, Eugenia

PY - 2011/7

Y1 - 2011/7

N2 - Backgound: The usefulness of coagulation tests performed before epidural analgesia for surgery or to alleviate labour pain is controversial. The aims of this study were: 1) to evaluate the prevalence of abnormal tests in a large cohort of healthy pregnant women and their association with epidural hematoma; 2) to assess the approach of the anesthesiologists to women with abnormal tests; 3) to evaluate the cost of performing coagulation tests before epidural analgesia in all healthy pregnant women. Methods: Data regarding epidural analgesia, epidural hematoma, PT, APTT, fibrinogen and platelet count were extracted from medical charts. Results: There was no case of epidural hematoma in 2546 pregnant women undergoing epidural analgesia. PT and APTT results were obtained in 2871 women; fibrinogen in 4063 women; platelet count in 5090 women. Three of them (0.1%) had a prolonged PT, 4 (0.14%) had a prolonged APTT, 27 (0.53%) had platelets ≤100 × 109/L and 37 (0.91%) had plasma fibrinogen levels <3 g/L. No further tests were requested by the anesthesiologists in these women. Only women with platelets <80 × 109/L were denied epidural analgesia. Based on the data from the literature on the frequencies of epidural hematoma after epidural analgesia, a total cost ranging from 4.5 to 40 million Euros to perform coagulation tests would be necessary to avoid one case of epidural hematoma. Discussion: Unselected coagulation tests before epidural analgesia are not recommended, because epidural hematoma is extremely rare in healthy pregnant women and the cost of screening is not justified.

AB - Backgound: The usefulness of coagulation tests performed before epidural analgesia for surgery or to alleviate labour pain is controversial. The aims of this study were: 1) to evaluate the prevalence of abnormal tests in a large cohort of healthy pregnant women and their association with epidural hematoma; 2) to assess the approach of the anesthesiologists to women with abnormal tests; 3) to evaluate the cost of performing coagulation tests before epidural analgesia in all healthy pregnant women. Methods: Data regarding epidural analgesia, epidural hematoma, PT, APTT, fibrinogen and platelet count were extracted from medical charts. Results: There was no case of epidural hematoma in 2546 pregnant women undergoing epidural analgesia. PT and APTT results were obtained in 2871 women; fibrinogen in 4063 women; platelet count in 5090 women. Three of them (0.1%) had a prolonged PT, 4 (0.14%) had a prolonged APTT, 27 (0.53%) had platelets ≤100 × 109/L and 37 (0.91%) had plasma fibrinogen levels <3 g/L. No further tests were requested by the anesthesiologists in these women. Only women with platelets <80 × 109/L were denied epidural analgesia. Based on the data from the literature on the frequencies of epidural hematoma after epidural analgesia, a total cost ranging from 4.5 to 40 million Euros to perform coagulation tests would be necessary to avoid one case of epidural hematoma. Discussion: Unselected coagulation tests before epidural analgesia are not recommended, because epidural hematoma is extremely rare in healthy pregnant women and the cost of screening is not justified.

UR - http://www.scopus.com/inward/record.url?scp=79958072211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958072211&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2011.02.023

DO - 10.1016/j.thromres.2011.02.023

M3 - Article

C2 - 21435700

AN - SCOPUS:79958072211

VL - 128

SP - 18

EP - 20

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 1

ER -